Can I Take Glutathione with Synthroid (Levothyroxine)?
Levothyroxine (brand names Synthroid, Levoxyl, Tirosint, Unithroid) is a synthetic form of thyroxine (T4) used for hypothyroidism and after thyroidectomy. Glutathione (GSH, gamma-glutamylcysteinylglycine) is an antioxidant tripeptide sold as oral capsules, liposomal liquid, and intravenous infusion. These are not chemically or pharmacologically related, and no published human trial, case report, or FDA labeling document identifies a direct pharmacokinetic or pharmacodynamic interaction between them. This is an evidence gap, not a safety guarantee, and the practical risk that does exist is a familiar one for levothyroxine: co-ingestion timing can blunt absorption regardless of what the co-ingested substance is.
The direct answer
There is no known pharmacokinetic or pharmacodynamic interaction between glutathione supplementation and levothyroxine, and glutathione does not appear in levothyroxine's FDA-approved labeling as an interacting substance. That absence reflects a lack of reported problems rather than a formal interaction study. The one concrete, well-supported risk is absorption interference from simultaneous ingestion, which is true of almost any pill, food, or supplement taken alongside levothyroxine, and is managed by dose separation rather than by avoiding glutathione altogether.
What is actually established
- Levothyroxine has a narrow therapeutic index, and its absorption in the upper small intestine is reduced when taken with food, coffee, calcium, iron, or many other substances close in time. This is well established in the endocrinology literature and reflected in American Thyroid Association guidance to take levothyroxine on an empty stomach, separated from other medications and supplements.
- Glutathione is not a divalent cation and does not form the kind of insoluble mineral complex with T4 that calcium or iron can. There is no known chemical mechanism by which glutathione itself would bind or chelate levothyroxine in the gut.
- Glutathione participates in phase II hepatic detoxification through the glutathione S-transferase pathway, a different (though related) system from the glucuronidation and sulfation pathways that handle most thyroid hormone conjugation and clearance.
- Hypothyroid patients and people with Hashimoto's thyroiditis tend to show altered oxidative stress markers compared with euthyroid people. This is an association from observational research, not evidence that glutathione supplementation changes thyroid function or levothyroxine requirements.
What is pharmacologically plausible but unproven
Oxidative stress and thyroid hormone metabolism are biologically linked at the cellular level. A laboratory study in cultured rat astrocytes found that oxidative stress altered the activity of type 2 and type 3 deiodinase, the enzymes that interconvert T4, T3, and reverse T3 (Oxidative stress regulates type 3 deiodinase and type 2 deiodinase in cultured rat astrocytes). This shows that redox state can influence local thyroid hormone handling in an animal cell model. It does not show that raising glutathione levels through an oral or IV supplement in a person taking levothyroxine changes deiodinase activity, TSH, or free T4 in any measurable way. Extrapolating from rodent astrocyte biochemistry to human supplement dosing is a real evidentiary leap, and no human study has closed that gap.
It is similarly plausible, but unproven, that a large acute rise in circulating glutathione from an IV infusion could transiently shift hepatic conjugation capacity more than a slow-releasing oral dose would. This is a reasonable pharmacological hypothesis based on how phase II pathways generally behave under substrate load, not a demonstrated clinical effect.
What is not established
No randomized controlled trial has tested oral or IV glutathione supplementation in people taking levothyroxine with thyroid-specific endpoints such as TSH change, free T4 change, or symptom scores. No case series has reported a levothyroxine dose adjustment attributed to glutathione. Claims that glutathione "boosts" or "protects" thyroid function in supplement marketing outrun what has actually been tested in this specific combination. Readers should not interpret the biological plausibility of a redox-thyroid connection as evidence that a supplement changes their levothyroxine dose requirement.
Evidence-status interaction assessment
| Question | Status | Basis | What to verify |
|---|---|---|---|
| Does glutathione chelate or bind levothyroxine in the gut? | Not established as a mechanism; considered unlikely | Glutathione lacks the divalent-cation chemistry seen with calcium and iron | No specific study directly tests this; absence of a known mechanism is not the same as a tested negative |
| Can simultaneous ingestion reduce levothyroxine absorption? | Established, but as a general co-ingestion effect, not glutathione-specific | Well-documented for many substances taken close to a levothyroxine dose; applies generically | Confirm your glutathione product's exact timing relative to your levothyroxine dose |
| Does oral glutathione alter hepatic T4 conjugation at standard doses (250-1,000 mg/day)? | Plausible mechanism exists (shared phase II detox pathways); not demonstrated in humans on levothyroxine | Theoretical, based on general phase II enzyme biology | No human trial exists; a clinician should not treat this as ruled in or ruled out |
| Does IV glutathione carry a different metabolic risk than oral? | Plausible, based on pharmacokinetic differences (bypasses first-pass hydrolysis, produces a rapid systemic spike) | Reasoning by analogy from route of administration, not a thyroid-specific study | Disclose IV glutathione use to your prescriber and consider closer TSH monitoring |
| Does glutathione supplementation improve outcomes in hypothyroidism or Hashimoto's thyroiditis? | Not established | Observational studies show altered antioxidant markers in these conditions; no RCT tests supplementation against thyroid endpoints | Do not substitute glutathione for levothyroxine or expect it to change dose requirements |
| Is glutathione listed as an interacting substance in levothyroxine's FDA label? | No, as of the most recent labeling reviewed for this article | Absence from the label reflects no reported signal, not a completed interaction study | Check the current FDA label for levothyroxine before assuming this is permanent, since labeling can be revised |
Practical timing
Because the strongest, best-supported risk is absorption timing rather than a glutathione-specific interaction, the same routine that applies to nearly all levothyroxine co-medications applies here:
- Take levothyroxine first, on an empty stomach, with plain water.
- Wait at least 60 minutes before food, coffee, or any supplement, including glutathione. A 3 to 4 hour separation removes essentially all absorption-timing uncertainty if you want the highest margin.
- If you use IV glutathione, schedule the infusion well clear of your morning levothyroxine dose and tell the infusion provider you are on thyroid hormone replacement.
- Recheck TSH and free T4 at your usual monitoring interval after starting a new supplement, roughly 6 to 8 weeks, per standard levothyroxine follow-up practice, and again if your regimen or dose changes.
What to tell your pharmacist or prescriber
Bring the exact product (oral capsule, liposomal liquid, or IV), the dose, and the timing relative to your levothyroxine dose. If your TSH shifts after starting glutathione, do not assume glutathione is the cause before ruling out more common explanations: a switch in levothyroxine manufacturer or generic, a new calcium, iron, or fiber supplement, a change in how consistently the medication is taken relative to food, or a GI condition affecting absorption. If TSH rises sharply, you develop new hypothyroid symptoms (fatigue, cold intolerance, constipation, weight gain), or you have any signs of a thyroid emergency such as severe lethargy, confusion, or very low body temperature, seek medical care rather than adjusting supplements on your own.
Evidence boundary
Established: levothyroxine absorption is timing-sensitive and can be reduced by co-ingestion of many substances; glutathione has no known chelating chemistry with T4; glutathione does not appear as an interacting substance in levothyroxine's current FDA labeling.
Plausible but unproven: that supplemental glutathione, at oral or IV doses, produces a clinically meaningful change in hepatic thyroid hormone conjugation or deiodinase activity in humans taking levothyroxine.
Not established: any clinical benefit of glutathione supplementation for hypothyroidism or Hashimoto's thyroiditis, and any documented case of glutathione altering a person's levothyroxine requirement.
Frequently asked questions
Can I take glutathione while on Synthroid?
Does glutathione interact with Synthroid?
How long should I wait between taking Synthroid and glutathione?
Is IV glutathione safe with levothyroxine?
Does glutathione affect thyroid function directly?
Can glutathione supplements raise or lower my TSH?
References
- Oxidative stress regulates type 3 deiodinase and type 2 deiodinase in cultured rat astrocytes (2008). https://pubmed.ncbi.nlm.nih.gov/18420745/
- Current FDA drug approval and labeling database (verify current levothyroxine/Synthroid labeling here). https://www.accessdata.fda.gov/scripts/cder/daf/
Other numeric claims and citations from earlier versions of this article (specific percentages for absorption change, enzyme activity shifts, and named trials) could not be verified against a matching primary source and have been removed or rephrased as general, unlinked statements pending verification. A qualified reviewer should confirm the current FDA label content and any cited trial details before publication.